Canada lags behind on drug safety for children
It’s surprising to learn that much of the medications given to children in Canada have never been adequately studied or even formally approved for the conditions they are commonly prescribed to treat.
Martin Offringa is a Professor of Pediatrics at the University of Toronto, a practicing neonatologist and a Senior Scientist in Child Health Evaluative Sciences at The Hospital for Sick Children.
Terry P. Klassen is an advisor with EvidenceNetwork.ca, a pediatric emergency physician and clinical epidemiologist who is currently the CEO and Scientific Director of the Manitoba Institute of Child Health. He was the founding chair of Pediatric Emergency Research of Canada.